Vinorelbine tartrate

• Post Date:

  Apr 28,2014

• Expiry Date:

  Apr 28,2015

• Detailed Description:

  Cas No. :125317-39-7 Payment Method: T/T advance
  Product Name ：Vinorelbine tartrate
  Synonyms ：3',4'-Didehydro-4'-deoxy-C'-norvincaleukoblastine
  Molecular formula ：C45H54N4O8·2C4H6O6
  Molecular weight ：1079.11
  CAS NO. ：125317-39-7
  Appearance ：White or almost white crystalline powder
  Purity(HPLC) ：≥99.0%
  Quality standard ：USP36 EP7.0
  CEP No: R0-CEP 2009-394-Rev 01
  Packing ：10g/bag,20g/bag
  Storage conditions ：Protect from light, tightly sealed, freezer storage(less than -20℃).
  Descriptions ：It is an anti-cancer drug, semi-synthesis from derivative of vincamedine, which is for the equilibrium of microtubule protein or capillary's dynamical, suppressing polymerization of microtubule protein through G2 and the M. It is used for the treatment of the non-cellule lung cancer, transferring breast cancer, lymphoma, ovarian cancer, etc.

• CAS Registry Number:

  125317-39-7

• Synonyms:

  ;Vinorelbine bitartrate;3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine R-(R*,R*)-2-3-dihydroxybutanedioate (1:2) salt;Navelbine tartrate;Nvb;Navelbine;Vinorelbin;Bitartrate;Vinorelbine ditartaric acid;Vinorelbine ditartrate salt;Butanedioate(1:2);C'-norvincaleukoblastine,3',4'-didehydro-4'-dioxy-,(R-(R*,R*))-2,3-dihydroxy;5'-noranhydrovinoblastine tartrate;3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine;[R-(R*,R*)-2-3-dihydroxybutanedioate (1:2) salt];Pacilitaxel;Vinorelbineditartrate salt hydrate;Vinorelbine tartrate usp standard;Vinorelbine tartrate;Vinorelbine bitratrate;Vinorelbine tartarate;methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate 2,3-dihydroxybutanedioate (1:2);methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate 2,3-dihydroxybutanedioate (1:2);methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate;(3Ar,3A1R,4R,5S,5Ar,10Br)-Methyl 4-Acetoxy-3A-Ethyl-9-((2S,6S,8S)-4-Ethyl-8-(Methoxycarbonyl)-1,3,6,7,8,9-Hexahydro-2,6-Methanoazecino[4,3-B]Indol-8-Yl)-5-Hydroxy-8-Methoxy-6-Methyl-3A,3A1,4,5,5A,6,11;

• Molecular Formula:

  C₄₅H₅₄N₄O₈

• Molecular Weight:

  778.9323

• Molecular Structure:

  

• Hazard Symbols:

   Xi:Irritant;
  

• Risk Codes:

  R43:;
  

• Safety Description:

  S26:;
  S36:;
  

• Company:

  Hubei Honch Pharmaceutical Co.,Ltd     [ China ]        

• Contact:

  Emily

• Tel:

  +86-713-7229222

• Fax:

  +86-713-7223777

• Email:

  vet@hcpharm.com